A Nine-Amino Acid Peptide from IL-1β Augments Antitumor Immune Responses Induced by Protein and DNA Vaccines

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5503-5511

  Hakim, Itzhak ^a   Levy, Shoshana ^a   Levy, Ronald ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 1; PEPTIDE; RECOMBINANT VACCINE; TUMOR ANTIGEN;

ANIMAL; ARTICLE; B CELL LYMPHOMA; C3H MOUSE; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOLOGY; MOUSE; PROTEIN SECONDARY STRUCTURE;

ANIMALS; ANTIGENS, NEOPLASM; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN IDIOTYPES; INTERLEUKIN-1; LYMPHOMA, B-CELL; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0030589297     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Maloney, D. G., M. S. Kaminski, D. Burowski, J. Haimovich, and R. Levy. 1985. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4:191.
2. 2 fragments against idiotypic determinants of its cell surface IgM. J. Immunol. 131:1600.
3. Stevenson, F. K., D. Zhu, C. A. King, L. J. Ashworth, S. Kumar, and R. E. Hawkins. 1995. Idiotypic DNA vaccines against B-cell lymphoma. Immunol. Rev. 145:211.
4. Kaminski, M. S., K. Kitamura, D. G. Maloney, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: inhibition of tumor immunity by free idiotype protein. J. Immunol. 138:1289.
5. Campbell, M. J., W. Carroll, S. Kon, K. Thielemans, J. B. Rothbard, S. Levy, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J. Immunol. 139:2825.
6. Campbell, M. J., L. Esserman, and R. Levy. 1988. Immunotherapy of established murine B cell lymphoma: combination of idiotype immunization and cyclophosphamide. J. Immunol. 141:3227.
7. Campbell, M. J., L. Esserman, N. E. Byars, A. C. Allison, and R. Levy. 1989. Development of a new therapeutic approach to B cell malignancy: the induction of immunity by the host against cell surface receptor on the tumor. Int. Rev. Immunol. 4:251.
8. Campbell, M. J., L. Esserman, N. E. Byars, A. C. Allison, and R. Levy. 1990. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145:1029.
9. Miller, R. A., D. G. Maloney, R. Warnke, and R. Levy. 1982. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306:517.
10. Miller, R. A., D. Maloney, and R. Levy. 1984. Monoclonal antibodies in the treatment of human leukemias and lymphomas: applications of flow cytometry. Ann. NY Acad. Sci. 428:49.
11. Brown, S. L., R. A. Miller, S. J. Horning, D. Czerwinski, S. M. Hart, R. McElderry, T. Basham, R. A. Warnke, T. C. Merigan, and R. Levy. 1989. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination wild alpha interferon. Blood 73:651.
12. Meeker, T. C., J. Lowder, D. G. Maloney, R. A. Miller, K. Thielemans, R. Warnke, and R. Levy. 1985. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65:1349.
13. Kwak, L. W., M. J. Campbell, D. K. Czerwinski, S. Hart, R. A. Miller, and R. Levy. 1992. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327:1209.
14. Hsu, F. J., L. Kwak, M. Campbell, T. Liles, D. Czerwinski, S. Hart, A. Syrengelas, R. Miller, and R. Levy. 1993. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann. NY Acad. Sci. 690:385.
15. Hsu, F. J., C. Benike, F. Fagnoni, T. M. Liles, D. Czerwinski, B. Taidi, E. G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52.
16. Meeker, T., J. Lowder, M. L. Cleary, S. Stewart, R. Warnke, J. Sklar, and R. Levy. 1985. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N. Engl. J. Med. 312:1658.
17. Cleary, M. L., T. C. Meeker, S. Levy, E. Lee, M. Trela, J. Sklar, and R. Levy. 1986. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma Cell 44:97.
18. Tao, M. H., and R. Levy. 1993. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755.
19. Chen, T. T., M. H. Tao, and R. Levy. 1994. Idiotype-cytokine fusion proteins as cancer vaccines: relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 153:4775.
20. Skerra, A., and A. Pluckthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038.
21. Better, M., and A. H. Horwitz. 1989. Expression of engineered antibodies and antibody fragments in microorganisms. Methods Enzymol. 178:476.
22. Pluckthun, A. 1990. Antibodies from Escherichia coli. Nature 347:497.
23. Pluckthun. A. 1991. Antibody engineering: advances from the use of Escherichia coli expression systems. Biotechnology 9:545.
24. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature 349:293.
25. Hoogenboom, H. R., and G. Winter. 1992. By-passing immunisation: human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227:381.
26. Marks, J. D., A. D. Griffiths, M. Malmqvist, T. P. Clackson, J. M. Bye, and G. Winter. 1992. By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology 10:779.
27. Pluckthun, A., R. Glockshuber, I. Pfitzinger, A. Skerra, and J. Stadlmuller. 1987. Engineering of antibodies with a known three-dimensional structure. Cold Spring Harbor Symp. Quant. Biol. 52:105.
28. Pluckthun, A., and A. Skerra. 1989. Expression of functional antibody Fv and Fab fragments in Escherichia coli. Methods Enzymol. 178:497.
29. Skerra, A., and A. Pluckthun. 1991. Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines. Protein Eng. 4:971.
30. Antoni, G., R. Presentini, F. Perin, A. Tagliabue, P. Ghiara, S. Censini, G. Volpini, L. Villa, and D. Boraschi. 1986. A short synthetic peptide fragment of human interleukin I with immunostimulatory but not inflammatory activity. J. Immunol. 137:3201.
31. Beckers, W., L. Villa, S. Gonfloni, L. Castagnoli, S. M. Newton, G. Cesareni, and P. Ghiara. 1993. Increasing the immunogenicity of protein antigens through the genetic insertion of VQGEESNDK sequence of human IL-1β into their sequence. J. Immunol. 151:1757.
32. Boraschi, D., L. Nencioni, L. Villa, S. Censini, P. Bossu, P. Ghiara, R. Presentini, F. Perin, D. Frasca, G. Doria, G. Forui, T. Musso, M. Giovarelli, P. Ghezzi, R. Bertini, H. O. Besedovsky, A. del Rey, J. D. Sipe, G. Antoni, S. Silvestri, and A. Tagliabue. 1988. In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1β. J. Exp. Med. 168:675.
33. Tagliabue, A., P. Ghiara, and D. Boraschi. 1992. Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvants. Res. Immunol. 143:563.
34. Boraschi, D., P. Bossu, P. Ruggiero, A. Tagliabue, R. Bertini, G. Macchia, C. Gasbarro, L. Pellegrini, G. Melillo, E. Ulisse, U. Visconti, C. Bizzari, E. DelGrosso, A. R. Mackay, G. Frascotti, F. Frigerio, R. Grifantini, and G. Grandi. 1995. Mapping of receptor binding sites on IL-1β by reconstruction of IL-1Ra-like domains. J. Immunol. 155:4719.
35. Tagliabue, A., and D. Boraschi. 1993. Cytokines as vaccine adjuvants: interleukin I and its synthetic peptide 163-171. Vaccine 11:594.
36. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Lin. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259:1745.
37. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11:957.
38. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 90:4156.
39. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1995. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:79.
40. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165.
41. Webster, R. G., E. F. Fynan, J. C. Santoro, and H. Robinson. 1994. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12:1495.
42. Zarozinski, C. C., E. F. Fynan, L. K. Selin, H. L. Robinson, and R. M. Welsh. 1995. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:4010.
43. Watanabe, A., E. Raz, H. Kohsaka, H. Tighe, S. M. Baird, T. J. Kipps, and D. A. Carson. 1993. Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151:2871.
44. Srikantan, V., B. Wang, M. A. Satre, K. E. Ugen, K. Dang, F. Scales, A. P. Godillot, W. V. Williams, and D. B. Weiner. 1994. Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1. AIDS 8:1525.
45. Stevenson, F. K., D. Zhu, C. A. King, L. J. Ashworth, S. Kumar, A. Thompsett, and R. E. Hawkins. 1995. A genetic approach to idiotypic vaccination for B cell lymphoma. Ann. NY Acad. Sci. 772:212.
46. Syrengelas, A. D., T. T. Chen, and R. Levy. 1996. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med. 2:1038.
47. Bergman, Y., and J. Haimovich. 1977. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur. J. Immunol. 7:413.
48. Starnes, C. O., W. L. Carroll, M. J. Campbell, L. L. Houston, G. Apell, and R. Levy. 1988. Heterogeneity of a murine B cell lymphoma: isolation and characterization of idiotypic variants. J. Immunol. 141:333.
49. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610.
50. Carroll, W. L., C. O. Starnes, R. Levy, and S. Levy. 1988. Alternative V kappa gene rearrangements in a murine B cell lymphoma: an explanation for idiotypic heterogeneity. J. Exp. Med. 168:1607.
51. Lei, S. P., H. C. Lin, S. S. Wang, J. Callaway, and G. Wilcox. 1987. Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J. Bacteriol. 169:4379.
52. Reff, M. E., K. Carner, K. S. Chambers, P. C. Chinn, J. E. Leonard, R. Raab, R. A. Newman, N. Hanna, and D. R. Anderson. 1994. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435.
53. Ward, E. S., D. Gussow, A. D. Griffiths, P. T. Jones, and G. Winter. 1989. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341:544.
54. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827.
55. Nencioni, L., L. Villa, A. Tagliabue, and D. Boraschi. 1987. Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes. Lymphokine Res. 6:335.
56. Nencioni, L., L. Villa, A. Tagliabue, G. Antoni, R. Presentini, F. Perin, S. Silvestri, and D. Boraschi. 1987. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J. Immunol. 139:800.
57. Chen, T. T., and R. Levy. 1995. Induction of autoantibody responses to GM-CSF by hyperimmunization with an Id-GM-CSF fusion protein. J. Immunol. 154:3105.
58. Kaminski, M. S., K. Kitamura, D. G. Maloney, M. J. Campbell, and R. Levy. 1986. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma: a study of hybridoma class switch variants. J. Immunol. 136:1123.
59. George, A. J., S. G. Folkard, T. J. Hamblin, and F. K. Stevenson. 1988. Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol. 141:2168.
60. Hawkins, R. E., G. Winter, T. J. Hamblin, F. K. Stevenson, and S. J. Russell. 1993. A genetic approach to idiotypic vaccination. J. Immunother. 14:273.